Increased staining for phospho-Akt, p65/RELA and cIAP-2 in pre-neoplastic human bronchial biopsies

Department of Environmental Health, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
BMC Cancer (Impact Factor: 3.36). 02/2005; 5(1):155. DOI: 10.1186/1471-2407-5-155
Source: PubMed

ABSTRACT The development of non-small cell lung carcinoma proceeds through a series of well-defined pathological steps before the appearance of invasive lung carcinoma. The molecular changes that correspond with pathology changes are not well defined and identification of the molecular events may provide clues on the progression of intraepithelial neoplasia in the lung, as well as suggest potential targets for chemoprevention. The acquisition of anti-apoptotic signals is critical for the survival of cancer cells but the pathways involved are incompletely characterized in developing intra-epithelial neoplasia (IEN).
We used immunohistochemistry to determine the presence, relative levels, and localization of proteins that mediate anti-apoptotic pathways in developing human bronchial neoplasia.
Bronchial epithelial protein levels of the phosphorylated (active) form of AKT kinase and the caspase inhibitor cIAP-2 were increased in more advanced grades of bronchial IEN lesions than in normal bronchial epithelium. Additionally, the percentage of biopsies with nuclear localization of p65/RELA in epithelial cells increased with advancing pathology grade, suggesting that NF-kappaB transcriptional activity was induced more frequently in advanced IEN lesions.
Our results indicate that anti-apoptotic pathways are elevated in bronchial IEN lesions prior to the onset of invasive carcinoma and that targeting these pathways therapeutically may offer promise in prevention of non-small cell lung carcinoma.

Download full-text


Available from: Yu Zhang, Sep 28, 2015
31 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: A CFAR adaptive polarimetric generalized likelihood ratio test (GLRT) detector is proposed for the coherent detection of radar targets against a Gaussian background and its performance is fully characterized. A model based version of such a detector is also derived by applying a similar GLRT approach to a structured covariance matrix. This latter detector is shown to reduce the adaptivity losses and thus to reduce the homogeneous region, which is required to estimate the clutter covariance matrix. The application to live radar data demonstrates the performance improvement achievable in practice by exploiting the polarimetric information. In particular adding the HV channel to the two co-polarized channels can provide a sensible performance increase with respect to the HH and VV only. This is especially true for man-made targets having cross-polarized response higher than the clutter. When the target has a lower cross-polarized return than the clutter, a much lower improvement is available but there is not a sensible adaptivity loss and the CFAR characteristic is always enforced against the Gaussian background
    Radar Conference, 2000. The Record of the IEEE 2000 International; 02/2000
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: BACKGROUND.Nuclear factor-κB (NF-κB), a key transcription factor thought to play a major role in carcinogenesis, regulates many important signaling pathways involved in tumor promotion. Although NF-κB can be activated in lung cancer cell lines by tobacco exposure, there have been no studies of the expression of NF-κB in lung cancer pathogenesis.METHODS.The immunohistochemical expression of NF-κB p65 was investigated in 394 lung cancers (370 nonsmall cell lung carcinomas [NSCLC]; and 24 small cell lung carcinomas [SCLC]) and 269 lung normal epithelium and preneoplastic lesions, including hyperplasias, squamous metaplasias, dysplasias, and atypical adenomatous hyperplasias.RESULTS.High levels of nuclear immunohistochemical expression of NF-κB p65 were detected in the lung cancers, with significantly higher levels in SCLCs compared with NSCLCs (P<.0001). In adenocarcinomas the NF-κB p65 expression level was significantly higher in advanced TNM stages (III-IV) than in earlier stages (I-II) (P<.0001), and when NF-κB p65 is dichotomized using 50% as the cutoff point (high vs low), a higher NF-κB p65 expression level was detected in tumors having either K-RAS (P = .02) or EGFR (P = .009) mutations compared with wildtype tumors. A relatively high level of nuclear NF-κB p65 expression was detected in normal and mildly abnormal epithelium, and a progression with increasing histology severity was detected in preneoplastic lesions.CONCLUSIONS.NF-κB p65 nuclear expression is an early and frequent phenomenon in the pathogenesis of lung cancer. The findings indicate that NF-κB activation plays an important role in lung cancer pathogenesis and is a suitable target for the development of new lung cancer therapies and chemoprevention strategies. Cancer 2006. © 2006 American Cancer Society.
    Cancer 12/2006; 107(11):2637 - 2646. DOI:10.1002/cncr.22315 · 4.89 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Despite the use of chemotherapy, radiation therapy, and surgery, the overall outcome for lung cancer continues to be disappointing. In order to make a difference in the treatment of lung cancer, novel therapeutics need to be developed. The molecular mechanisms of carcinogenesis in lung cancer are complex and involve multiple oncogenes, tumor suppressor genes, receptor tyrosine kinases, cytoplasmic enzymes, and tumor interstitial elements, among other cellular proteins. In this review, the authors discuss key signaling pathways and molecular targets in the treatment of lung cancer. Through understanding molecular targets and the utilization of specific inhibitors, hopefully, a dramatic impact will be made in the biology and therapy of lung cancer.
    Clinical Lung Cancer 03/2007; 8 Suppl 2:S52-60. DOI:10.3816/CLC.2007.s.002 · 3.10 Impact Factor
Show more